Table 1.
Number | 125 | 178 | 1 | 1 |
---|---|---|---|---|
Non-Competition Horses | Racing- Thoroughbreds | Clinical Case I | Clinical Case II | |
Median Age (Range) | 5 (2–24) | 9 (4–18) | 11 | 14 |
Sexes | 56 Mares, 69 Geldings |
178 Geldings | Gelding | Mare |
Breed(s) | TB, QH, Drafts, Arabians, WB | TB | TB | QH |
Resting hscTnT Mean (±SD), ng/L |
3.6 (±2.1) | 5.4 (±3.8) | 221.0a | 5723.0b |
hscTnT Median, ng/L | 3.0 | 4.0c | N/A | N/A |
hscTnT Range, ng/L | 3.0–17.0 | 3.0–24.0 | N/A | N/A |
hscTnT 95 % URL (90 % CI), ng/L | 6.79 (6.0–12.0) |
14.0 (10.0–18.0) |
N/A | N/A |
hscTnT 99 % URL (90 % CI), ng/L | 16.2 (N/A) |
23.2 (N/A) |
N/A | N/A |
Comparison of ages, sexes, breeds and resting heparin plasma hscTnT concentrations from 303 apparently healthy horses (Non-Competition Horses and Racing-Thoroughbreds) as well as two clinical cases
aHeparin plasma hscTnT sample taken 5 h after race-induced upper respiratory crisis event
bHeparin plasma hscTnT sample taken 41 h after initially presented to clinic
cIndicates a significant difference from Non-Competition Horses